Glucotrack, Inc. Equity, Fair Value Disclosure
Glucotrack, Inc. (GCTK) had Equity, Fair Value Disclosure of $1.50 million as of 2024-09-05, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
us-gaap:EquityFairValueDisclosure · last filed 2026-03-30
- 2024-09-05: Equity, Fair Value Disclosure $1.50M.
- 2024-08-23: Equity, Fair Value Disclosure $238.00K.
| Period end | Equity, Fair Value Disclosure |
|---|---|
| 2024-09-05 | $1.50M 10-K · filed 2026-03-30 |
| 2024-08-23 | $238.00K 10-K · filed 2026-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |